×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OKUR – onkure therapeutics, inc. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OKUR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/8
02:32 pm
okur
OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
11/5
04:05 pm
okur
OnKure to Present at the Stifel 2024 Healthcare Conference
Medium
Report
OnKure to Present at the Stifel 2024 Healthcare Conference
11/1
05:33 pm
okur
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium [Yahoo! Finance]
Low
Report
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium [Yahoo! Finance]
11/1
05:30 pm
okur
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
Low
Report
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
10/24
03:35 pm
okur
OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond [Seeking Alpha]
Low
Report
OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond [Seeking Alpha]
10/23
05:15 pm
okur
OnKure files to sell 2.94M shares of Class A Common Stock for holders [Seeking Alpha]
Medium
Report
OnKure files to sell 2.94M shares of Class A Common Stock for holders [Seeking Alpha]
10/17
10:38 am
okur
OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
10/11
06:05 am
okur
OnKure Therapeutics (NASDAQ: OKUR) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Medium
Report
OnKure Therapeutics (NASDAQ: OKUR) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:00 pm
okur
Form SC 13G/A OnKure Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Low
Report
Form SC 13G/A OnKure Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
11/14
10:12 am
okur
Form SC 13G OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Low
Report
Form SC 13G OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
11/7
04:21 pm
okur
Form 424B3 OnKure Therapeutics,
Low
Report
Form 424B3 OnKure Therapeutics,
11/7
04:05 pm
okur
Form 8-K OnKure Therapeutics, For: Nov 07
Low
Report
Form 8-K OnKure Therapeutics, For: Nov 07
11/7
04:01 pm
okur
Form 10-Q OnKure Therapeutics, For: Sep 30
Low
Report
Form 10-Q OnKure Therapeutics, For: Sep 30
10/31
04:11 pm
okur
Form 424B3 OnKure Therapeutics,
Medium
Report
Form 424B3 OnKure Therapeutics,
10/31
06:04 am
okur
Form EFFECT OnKure Therapeutics,
Low
Report
Form EFFECT OnKure Therapeutics,
10/28
04:03 pm
okur
Form SC 13G/A OnKure Therapeutics, Filed by: Octagon Capital Advisors LP
Low
Report
Form SC 13G/A OnKure Therapeutics, Filed by: Octagon Capital Advisors LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: